fda category 2 bulk drug substances bpc-157 compounding list has removed certain that were placed on the two and has announced it will consult the Pharmacy Advisory Committee (PCAC) for potential future inclusion of FDA panel backs compounded BPC-157,
FDA panel backs compounded BPC 157, KPV peptides in win for RFK Jr. STAT FDA panel votes to place popular peptide BPC 157 on compounding list Reuters FDA considers adding a dozen peptides to its bulk drug compounding list RAPS This just in: The FDA is proposing to move 14 commonly used peptides from Category 2 to Category 1 on the compounding review list If finalized, this shift could significantly change FDA Peptide Reclassification 2026: What It Means for Providers A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring!
Pay in 4 interest-free payments of $6.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



